Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Biopsy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06371989
What this trial is testing

Vacuum Assisted Biopsy and Surgery Correlation in HER2 and TN Breast Cancer Subtypes MRI Responders After Neoadjuvant Therapy: BISUCO TRIAL

Who this might be right for
Breast CancerBreast Biopsy
Hospital Universitario 12 de Octubre 25
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Not applicableStudy completedNCT01622478
What this trial is testing

Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes

Who this might be right for
Breast Cancer
Gangnam Severance Hospital 120
Not applicableStudy completedNCT02575612
What this trial is testing

Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
Heidelberg University 50
Not applicableStudy completedNCT04107636
What this trial is testing

Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance

Who this might be right for
Breast Cancer
Radboud University Medical Center 45
Not applicableStudy completedNCT00450723
What this trial is testing

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
University of Miami 39
Not applicableStudy completedNCT04482803
What this trial is testing

Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for CN+ Breast Cancer

Who this might be right for
Location and Biopsy of Axillary Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University 159
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Not applicableEnded earlyNCT03648983
What this trial is testing

Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer

Who this might be right for
LymphedemaBreast Cancer
Albert Einstein College of Medicine 95
Not applicableStudy completedNCT00087347
What this trial is testing

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Who this might be right for
Breast CancerProstate Cancer
Massachusetts General Hospital 14
Not applicableStudy completedNCT05779982
What this trial is testing

SURPASS Retrospective Study

Who this might be right for
Breast CancerBreast MRINeoadjuvant Systemic Therapy+1 more
Gangnam Severance Hospital 500
Not applicableStudy completedNCT00776308
What this trial is testing

Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery

Who this might be right for
Breast Cancer
Mayo Clinic 98
Testing effectiveness (Phase 2)Study completedNCT00003099
What this trial is testing

Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 52
Post-approval studies (Phase 4)Study completedNCT03038152
What this trial is testing

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7+3 more
M.D. Anderson Cancer Center 54
Not applicableEnded earlyNCT03520127
What this trial is testing

A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

Who this might be right for
Breast Lesions
Medtronic Surgical Technologies 176
Testing effectiveness (Phase 2)Study completedNCT05359783
What this trial is testing

Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide

Who this might be right for
Breast CancerSentinel Lymph Node
Vastra Gotaland Region 50
Testing effectiveness (Phase 2)Looking for participantsNCT05190094
What this trial is testing

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

Who this might be right for
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
International Cancer Research Group, United Arab Emirates 80
Testing effectiveness (Phase 2)Study completedNCT00574301
What this trial is testing

Percutaneous Removal and Margin Ablation for Breast Cancer

Who this might be right for
Breast Cancer
University of Arkansas 32
Not applicableStudy completedNCT00357487
What this trial is testing

Evaluation of Two New Medical Instruments Dedicated to the Sentinel Lymph Node Technique in Case of Breast Cancer

Who this might be right for
Breast Cancer
University Hospital, Strasbourg, France 25
Not applicableLooking for participantsNCT06417801
What this trial is testing

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 170
Next Page